BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 14, 2026
Home
»
Authors
» James Etheridge
James Etheridge
Articles
ARTICLES
CareX Raises EUR25M in Second Round To Fund Development
March 10, 2004
By
James Etheridge
CareX Brings In EUR25M To Fund Advancement Into Clinical Trials
March 9, 2004
By
James Etheridge
CareX Brings In EUR25M To Fund Advancement Into Clinical Trials
March 9, 2004
By
James Etheridge
Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines
March 3, 2004
By
James Etheridge
Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines
March 3, 2004
By
James Etheridge
ExonHit Raises Additional EUR8.3M; Now Has Cash To Last Into 2006
Feb. 4, 2004
By
James Etheridge
ExonHit Raises Additional EUR8.3M; Now Has Cash To Last Into 2006
Feb. 4, 2004
By
James Etheridge
ProSkelia, BioXell Enter Alliance To Develop Vitamin 3D Analogues
Jan. 21, 2004
By
James Etheridge
Cerep Broadening Services Via $12.9M Acquisition of Hesperion
Jan. 21, 2004
By
James Etheridge
ProSkelia, BioXell Enter Alliance To Develop Vitamin 3D Analogues
Jan. 21, 2004
By
James Etheridge
View All Articles by James Etheridge
